Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Report

Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report By Product (Gene Therapy, Cell Therapy), By Phase, By Indication, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-676-6
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Advanced Therapy Medicinal Products CDMO Product Outlook (USD Million, 2018 - 2030)
- Gene Therapy
- Cell Therapy
- Tissue Engineered
- Others
Advanced Therapy Medicinal Products CDMO Phase Outlook (USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Advanced Therapy Medicinal Products CDMO Indication Outlook (USD Million, 2018 - 2030)
- Oncology
- Cardiology
- Central nervous system
- Musculoskeletal
- Infectious disease
- Dermatology
- Endocrine, metabolic, genetic
- Immunology & inflammation
- Ophthalmology
- Hematology
- Gastroenterology
- Others
Advanced Therapy Medicinal Products CDMO Regional Outlook (USD Million, 2018 - 2030)
- North America
  - North America Advanced Therapy Medicinal Products CDMO Market, By Product
    - Gene Therapy
    - Cell Therapy
    - Tissue Engineered
    - Others
  - North America Advanced Therapy Medicinal Products CDMO Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - North America Advanced Therapy Medicinal Products CDMO Market, By Indication
    - Oncology
    - Cardiology
    - Central nervous system
    - Musculoskeletal
    - Infectious disease
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - U.S.
    - U.S. Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - U.S. Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.S. Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central Nervous System
      - Musculoskeletal
      - Infectious Disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Hematology
      - Gastroenterology
      - Others
  - Canada
    - Canada Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Canada Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Canada Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Europe
  - Europe Advanced Therapy Medicinal Products CDMO Market, By Product
    - Gene Therapy
    - Cell Therapy
    - Tissue Engineered
    - Others
  - Europe Advanced Therapy Medicinal Products CDMO Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Europe Advanced Therapy Medicinal Products CDMO Market, By Indication
    - Oncology
    - Cardiology
    - Central nervous system
    - Musculoskeletal
    - Infectious disease
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - UK
    - UK Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - UK Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UK Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Germany
    - Germany Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Germany Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Germany Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - France
    - France Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - France Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - France Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Italy
    - Italy Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Italy Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Italy Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Spain
    - Spain Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Spain Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Spain Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Sweden
    - Sweden Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Sweden Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Sweden Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Norway
    - Norway Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Norway Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Norway Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Denmark
    - Denmark Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Denmark Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Denmark Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Asia Pacific
  - Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Product
    - Gene Therapy
    - Cell Therapy
    - Tissue Engineered
    - Others
  - Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Asia Pacific Advanced Therapy Medicinal Products CDMO Market, By Indication
    - Oncology
    - Cardiology
    - Central nervous system
    - Musculoskeletal
    - Infectious disease
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - Japan
    - Japan Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Japan Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Japan Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - China
    - China Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - China Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - China Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - India
    - India Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - India Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - India Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Australia
    - Australia Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Australia Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Australia Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - South Korea
    - South Korea Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - South Korea Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Korea Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Thailand
    - Thailand Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Thailand Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Thailand Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- Latin America
  - Latin America Advanced Therapy Medicinal Products CDMO Market, By Product
    - Gene Therapy
    - Cell Therapy
    - Tissue Engineered
    - Others
  - Latin America Advanced Therapy Medicinal Products CDMO Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Latin America Advanced Therapy Medicinal Products CDMO Market, By Indication
    - Oncology
    - Cardiology
    - Central nervous system
    - Musculoskeletal
    - Infectious disease
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - Brazil
    - Brazil Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Brazil Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Brazil Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Mexico
    - Mexico Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Mexico Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Mexico Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Argentina
    - Argentina Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Argentina Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Argentina Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
- MEA
  - MEA Advanced Therapy Medicinal Products CDMO Market, By Product
    - Gene Therapy
    - Cell Therapy
    - Tissue Engineered
    - Others
  - MEA Advanced Therapy Medicinal Products CDMO Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - MEA Advanced Therapy Medicinal Products CDMO Market, By Indication
    - Oncology
    - Cardiology
    - Central nervous system
    - Musculoskeletal
    - Infectious disease
    - Dermatology
    - Endocrine, metabolic, genetic
    - Immunology & inflammation
    - Ophthalmology
    - Hematology
    - Gastroenterology
    - Others
  - South Africa
    - South Africa Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - South Africa Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Africa Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Saudi Arabia
    - Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Saudi Arabia Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - UAE
    - UAE Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - UAE Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UAE Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others
  - Kuwait
    - Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Product
      - Gene Therapy
      - Cell Therapy
      - Tissue Engineered
      - Others
    - Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Kuwait Advanced Therapy Medicinal Products CDMOMarket, By Indication
      - Oncology
      - Cardiology
      - Central nervous system
      - Musculoskeletal
      - Infectious disease
      - Dermatology
      - Endocrine, metabolic, genetic
      - Immunology & inflammation
      - Ophthalmology
      - Hematology
      - Gastroenterology
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.